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Abstract
Background We tested the added value of 3D-vision on procedure time and surgical performance during robotic pancrea-
toduodenectomy anastomoses in biotissue. Robotic surgery has the advantage of articulating instruments and 3D-vision. 
Consensus is lacking on the added value of 3D-vision during laparoscopic surgery. Given the improved dexterity with robotic 
surgery, the added value of 3D-vision may be even less with robotic surgery.
Methods In this experimental randomized controlled cross-over trial, 20 surgeons and surgical residents from 5 countries 
performed robotic pancreaticojejunostomy and hepaticojejunostomy anastomoses in a biotissue organ model using the 
da Vinci® system and were randomized to start with either 3D- or 2D-vision. Primary endpoint was the time required to 
complete both anastomoses. Secondary endpoint was the objective structured assessment of technical skill (OSATS; range 
12–60) rating; scored by two observers blinded to 3D/2D.
Results Robotic 3D-vision reduced the combined operative time from 78.1 to 57.3 min (24.6% reduction, p < 0.001; 20.8 min 
reduction, 95% confidence intervals 12.8–28.8 min). This reduction was consistent for both anastomoses and between 
surgeons and residents, p < 0.001. Robotic 3D-vision improved OSATS performance by 6.1 points (20.8% improvement, 
p = 0.003) compared to 2D (39.4 to 45.1 points, ± 5.5).
Conclusion 3D-vision has a considerable added value during robotic pancreatoduodenectomy anastomoses in biotissue in 
both time reduction and improved surgical performance as compared to 2D-vision.
Keywords Laparoscopy · Robot-assisted surgery · 3D · OSATS · Artificial organs
The morbidity rate of pancreatoduodenectomy is to a large 
extent caused by postoperative pancreatic fistula [1]. In 
recent years, minimally invasive PD has been introduced as 
a means to minimize the impact of surgery and thus enhance 
postoperative recovery [2]. Laparoscopic PD has the down-
side of non-articulating instruments and 2D-vision becomes 
especially apparent when creating pancreaticojejunostomy 
(PJ) and hepaticojejunostomy (HJ) anastomoses as during 
pancreatoduodenectomy [3, 4].
As stated by the 2020 international Miami evidence 
based guidelines on minimally invasive pancreatic resec-
tion, it is currently unclear whether the outcomes of general 
laparoscopic PD could benefit from 3D-vision [5]. More 
recently, the LAELAPS-3D2D study demonstrated a ben-
efit in operative time and operative quality by 3D-laparo-
scopic reconstructive pancreatic surgery [4]. The use of an 
operating robot may facilitate minimally invasive PD as it 
overcomes some of the difficulties as encountered in regular 
laparoscopic surgery by improving dexterity and articulating 
instruments [6–8]. Given these benefits, one could argue 
that the added value of 3D-vision is therefore less in robotic 
surgery as compared to laparoscopic surgery. For upcoming 
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robotic platforms, the question therefore remains whether 
robotic surgery should include 3D-vision [9, 10].
We aimed to determine the added value of 3D-vision, as 
compared to 2D-vision, when performing robotic pancrea-
toduodenectomy anastomoses in biotissue.
Methods
Study design
We conducted an experimental randomized controlled 
cross-over trial. The Consolidated Standards of Reporting 
Trials (CONSORT) guidelines where followed [11]. All 
participants were asked to complete a PJ and a HJ twice in 
an experimental setting using an artificial biotissue model 
simulating minimally invasive PD; once with 3D- and once 
with 2D-vision (see e-material 1 in the supplements for more 
detail on the procedures). The cross-over design with ran-
domization was intended to minimize inter-observer differ-
ences and the impact of familiarity. The study was assessed 
and approved by the local ethics committee and performed in 
accordance with the Declaration of Helsinki [12]. The local 
ethics committee decided no informed consent was required 
for participating in this study, hereafter the study protocol 
was made available on the Dutch Trial Register: NL8063.
Participants
Participants were invited from all 17 centers participating 
in the Dutch Pancreatic Cancer Group as well as from inter-
national collaborating centers. Sample size was calculated 
according to previous published data on laparoscopic 3D 
surgery, see statistical methods. The 20 participants included 
both expert surgeons and surgical residents, all of whom 
were capable of robotic suturing and completed a profi-
ciency based robotic simulation curriculum [13]. Experience 
with minimally invasive PD was not required for participa-
tion. Stereoptic abilities, i.e., 3D-vision capabilities, were 
assessed using a Randot Test (Stereo optical, Chicago, IL, 
USA). Reported side effects and preferences, and baseline 
demographics were collected using questionnaires (see eFig-
ure 1 in Supplements). Participants (n = 0) were excluded if 
they had no 3D-vision abilities, > 200 s of arc [14].
Intervention
The study was performed using the da Vinci® surgical robot 
in the operating rooms of 7 hospitals and at 2 experimental 
training facilities, always in the presence of the first author 
(MJZ) and performed during day-time hours. Participants 
first watched a 10 min instruction video and had an oral 
instruction before the start of the experiment.
A standardized patient setting was simulated using 
inanimate artificial, biotissue, organs (LifeLike BioTis-
sue, Ontario, Canada) according to the Minimally Invasive 
Pancreatic Resection Organizing Committee method (See 
Fig. 1) [13]. The artificial organs included a long pancreas, 
long double layer small bowel, bile duct, vessel holder, and 
skin holder. Several minimally invasive training programs 
have incorporated these synthetic artificial organs, one of 
which shows face- and construct validity in training PD [13]. 
An integrated 3D HD da Vinci robotic laparoscope was used 
(Intuitive Surgical Inc., Sunnyvale California, USA), resolu-
tion (high-definition/1280 × 1024) and lighting conditions 
were identical between interventions. Participants used the 
identical set of robotic instruments and camera for all cor-
responding cross-over exercises. Ergonomic conditions were 
adjusted for all subjects before starting the experiment.
Rating
All imaging material was presented to one rater and one 
validation rater anonymously, i.e., blinded for both the 
performing participant and for 3D/2D. The rater training 
was performed at University of Pittsburgh Medical Center. 
Fig. 1  Robotic pancreatoduodenectomy anastomoses in biotissue set-
up. Biotissue anastomoses set-up of the pancreaticojejunostomy (up) 
and hepaticojejunostomy (down)
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The validation rater was an experienced laparoscopic sur-
geon experienced in robotic pancreatoduodenectomy, who 
received a training in video rating. The validation rater 
received a random sample of 20 anastomoses of all anasto-
moses performed. The random sample was picked by a com-
puter algorithm. Performance was rated using an objective 
structured assessment of technical skill (OSATS) validated 
by Birkmeyer et al. and Tam et al. (see Table 1) [13, 15, 16].
Randomization
Randomization was done with SPSS (SPSS Inc., Chicago, 
IL, USA) by the study coordinator. Participant data were 
anonymized by using a 4-digit code, and the principal 
investigator and study coordinators were the only ones with 
access to the decoding document.
Outcomes
The primary outcome was the difference in total operative 
time expressed in minutes and percentages. Secondary out-
come was surgical performance according to the OSATS 
score (attainable range 12–60). Other outcomes were the 
difference in operative time for the PJ and HJ; participant’s 
preference for 3D or 2D, and side effects of 3D-vision.
Statistical methods
The sample size estimation for this trial was based on a pre-
vious randomized study assessing 3D laparoscopy (LAE-
LAPS-3D2D) [4]. Assuming a pooled standard deviation 
of 10 min, the study would require a sample size of: 10 
participants for each group, i.e., a total sample size of 20 
participants to achieve a power of 90% and a level of sig-
nificance of 5% (two sided), for detecting a true difference 
in means between the test and the reference group of 15 min. 
Power calculation did not focus on participant categoriza-
tion as surgeons or residents since no statistical difference 
was found in the LAELAPS-3D2D study, nonetheless, we 
reported on these results for our primary and secondary out-
come as means of sensitivity analysis [4].
Data were analyzed using IBM SPSS statistics for Win-
dows version 24 (IBM Corp, Armonk, NY, USA). Normally 
distributed continuous data were presented as means and 
standard deviations (±). Non-normally distributed con-
tinuous data were presented as medians and interquartile 
ranges (IQRs) or 95% confidence intervals (95% CI). Cat-
egorical (binary, nominal, and ordinal) data were presented 
as frequencies and percentages. Likert-Scale ordinal data 
were also presented in means and standard deviations, as 
this allows more insight into the effect size [17]. A two-
tailed p value of less than 0.05 was considered statistically 
significant. Missing data were corrected by excluding the 
corresponding missing part of the video of both the inter-
vention and control procedure into the analysis (n = 1, HJ, 
2 min due to recording failure). Differences in anastomosis 
times were analyzed paired-wise according to the perform-
ing participant.
Baseline demographics were compared with Student’s 
t-test for normally distributed data, Chi-squared test for fre-
quencies in one or more categories, and Mann–Whitney U 
test for non-normally distributed data. Primary outcomes 
were analyzed using the Wilcoxon signed-rank test, since 
the comparison was paired-wise. Secondary outcomes were 
Table 1  Elements of objective 
structured assessment of 
technical skill (OSATS)














Gentle tissue handling that does not 
result in injury
Economy of motion, maximum 
efficiency
Fluid use of instruments without 
awkwardness
Smooth transitions from one part of 
the operation to another
Retraction that allows for good 
visualization and proper tissue 
alignment
Overall assessment of technical 
skill
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analyzed using Wilcoxon signed-rank test and analysis 




In the period December 2017 to January 2019, over 30 sur-
geons and surgical residents were invited, resulting in 20 
participants of which 16 participants completed the experi-
ment in a single session. For detailed information on the 
numbers of participants randomly assigned, their performed 
procedures, and data analyzed, see Fig. 2. The 20 partici-
pants completed 40 PJs and 40 HJs.
Baseline demographics
Surgeons (n = 14) and residents (n = 6) from 5 countries 
(Belgium, Estonia, Italy, Japan, the Netherlands) par-
ticipated. The two groups, i.e., start with 3D or 2D, were 
comparable for baseline characteristics, robotic experience 
(13/14 surgeons and 1/6 residents had performed robotic 
surgery in clinical practice as console surgeon), hand domi-
nance, vision correction and 3D-vision abilities. Mean age 
was 35 years (± 8) and 16/20 participants were male (see 
Table 2). Among those who had performed robotic surgery, 
the median robotic experience was 1 year (IQR 1–2) with a 
median annual volume of 20 advanced robotic procedures 
(IQR 1–40). Of all participants, 8 (40%) performed MIPD, 
of which the median number of MIPDs performed was 23 
(IQR 13–48).
Primary outcomes
The mean operative time to complete both anastomo-
ses was 57.3 (± 14.3) min (median 56.0, IQR 47.5–67.3) 
with 3D-vision and 78.1 (± 20.5) min (median 75.5, IQR 
69.3–95.5) with 2D-vision. The median reduction in total 
operative time with 3D was 20.8 min, 95%CI 12.8–28.8, 
(p < 0.001). The relative reduction in operative time with 
3D was 24.6% (± 17.3), 95% CI 15.6–33.5 (p < 0.001), see 
Fig. 3.
The median operative time for the PJ was 37.2 min (IQR 
30.5–43.5) in 3D and 49.2 min (IQR 44.3–58.0) in 2D. The 
median reduction in PJ operative time with 3D was 11.2 min, 
95% CI 6.1–15.5 (p < 0.001), or 25.2%. The median opera-
tive time for the HJ was 19.5 min (IQR 16.4–27.2) in 3D 
and 27.5 min (IQR 23.5–40.1) in 2D. The median reduction 
in HJ operative time in 3D was 7.2 min, 95% CI 4.4–13.2 
(p < 0.001), or 29.6%. The benefit of 3D did not differ 
between both anastomoses (p = 0.163) (see Fig. 3). The rela-
tive improvements in operative time were 25.2%, 95% CI 
12.1–30.1 (p < 0.001), for PJ, and 29.6%, 95% CI 14.5–40.4 
(p < 0.001), for HJ.
Fig. 2  Flowchart of inclusion. 







Assessed for eligibility 24 
Randomized (n = 20) 
Allocated to 3D starting modality (n = 10) 
Received allocated intervention (n = 10) 
Excluded (n = 4) 
- Not meeting inclusion criteria (n = 0) 





s Analyzed (n = 10) 











 PJs completed: 20 
HJs completed: 20 
3 had time to complete one anastomosis 
type, initially 
Analyzed (n = 10) 
Excluded from analysis: (n = 0)
Allocated to 2D starting modality (n = 10) 
Received allocated intervention (n = 10) 
PJs completed: 20 
HJs completed: 20 
1 had time to complete one anastomosis 
type, initially 
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Secondary outcomes
The mean OSATS for both anastomoses was 45.1 (± 6.2) 
points using 3D-vision and 39.4 (± 9.2) points using 
2D-vision, with attainable scores between 12 and 60. The 
mean overall improvement in the OSATS for both anas-
tomoses with 3D-vision was 6.1 points, ± 5.5, p = 0.003. 
The relative improvement was 20.8%.
Of all participants, 20/20 participants stated to pre-
fer 3D-vision, whereas 4/20 reported side effects. Minor 
side effects, e.g., minor eyestrain, were reported by 3/20 
participants and 1/20 participants reported serious side 
effects, e.g., serious headache in relation to 3D-vision. 
Surprisingly, 2 participant reported side effects in relation 
to 2D-vision (see eTable 2 in Supplements).
The validation grading mean OSATS for both anas-
tomoses was 39.0 (± 4.3) points using 3D-vision and 
31.7 (± 1.9) points using 2D-vision with a mean overall 
improvement in the OSATS for both anastomoses with 
3D-vision of 7.3 points, ± 3.2, p = 0.027.
Surgeons and residents
The median reduction in operative time with 3D-vision was 
20.0 min, 95% CI 14.6–33.1 (p = 0.002), or 29.8%, for sur-
geons and 21.0 min, 95% CI 8.2–35.0 (p = 0.138), or 19.4%, 
for residents. The reduction in operative time with 3D did 
not differ significantly between surgeons and residents 
(p = 0.279).
The mean overall improvement in the OSATS for both 
anastomoses with 3D-vision was 6.0 points, ± 5.1, p = 0.005, 
or 17.9%, for surgeons and 6.4 points, ± 6.7, p = 0.099, or 
20.8%, for residents. The improvement did not differ signifi-
cantly between surgeons and residents, p = 0.615.
When stratifying outcome of surgeons in the 50% with 
the most experience and the 50% with the least experi-
ence we found a similar benefit of 3D-vision compared to 
2D-vision. For the stratum with higher experience median 
52.5 min versus 73.50 min, p = 0.012, respectively. For the 
stratum with lower experience median 58.5 min versus 
78.0 min, p = 0.025, respectively. For the stratum with higher 
Table 2  Participant characteristics
Values are mean ± SD, median (quartile 1 to quartile 3) or n (percentage)
a Students t-test
b Chi-square test
c Mann–Whitney U test








Age (years) 35 ± 8 36 ± 9 36 ± 4 0.719a
Male (%) 16 (80) 8 (80) 8 (80) 1.000b
Experience in minimally invasive surgery
 Surgeons 14 (80) 7 (80) 7 (80) 1.000b
  Clinical robotic  experienced 13/14 6/7 7/7
 Residents 6 (30) 3 (30) 3 (30) 1.000b
  Clinical robotic  experienced 1/6 0/3 1/3
 Years of robotic experience 1 (0–1.8) 1 (0–1.3) 1 (0–2.0) 0.872
 Number of advanced robotic procedures per-
formed annually
20 (1–40) 10 (0–36) 30 (4–50) 0.657c
 Performed minimally invasive pancreatoduo-
denectomies (MIPD) (%)
8 (40) 4 (40) 4 (40) 1.000b
  Number of MIPDs performed 23 (13–48) 16 (10–43) 33 (21–48) 0.343c
Hand dominance 0.589b (X2 = 1.059)
  Right (%) 18 (85) 8 (80) 9 (90)
  Left (%) 2 (10) 1 (10) 1 (10)
  Ambidextrous (%) 1 (5) 1 (10) 0 (-)
Vision correction (%) 8 (40) 5 (50) 3 (30) 0.581b
Minimal degrees of stereopsis, seconds of arc 50 (20–130) 60 (40–80) 100 (60–200) 0.108c
2933Surgical Endoscopy (2021) 35:2928–2935 
1 3
experience mean OSATS of 47.6 versus 42.3, p = 0.26, 
respectively. For the stratum with lower experience median 
OSATS of 42.0 versus 36.5, p = 0.021, respectively.
Discussion
This first experimental randomized study to examine the 
impact of robotic 3D-vision during pancreatoduodenec-
tomy anastomoses in biotissue found that 3D-vision reduced 
operative time by 25% and improved surgical performance 
with 21% (based on OSATS), as compared to 2D-vision. The 
benefit of 3D-vision on operative time, and its effect size, 
was similar between surgeons and residents during robotic 
surgery in an experimental setting, similar between surgeons 
with more and less experience, and was present for both the 
pancreatic and bile duct anastomoses.
It seems that 3D-vision had a similar, or even somewhat 
higher, advantage for surgical time and surgical performance 
with robotic surgery as compared to laparoscopic surgery. 
The present study followed the LAELAPS-3D2D rand-
omized trial that studied the same outcomes for 3D laparos-
copy [4]. In that study, 3D laparoscopy improved surgical 
time with 20% and surgical performance with 12%. A recent 
systematic review confirmed that 3D laparoscopy improved 
operative time and reduced the number of performance 
errors when compared to 2D-laparoscopy in abdominal sur-
gery and simulation surgery [3]. Recent randomized trials 
on laparoscopic versus open pancreatoduodenectomy did not 
take 3D-vision into account [18–20].
Birkmeyer et al. established that the complication rates 
nearly halves for every point increase in the numerical 
rating [16]. Lower OSATS performance scores have also 
been shown predictive of postoperative pancreatic fistulas 
in robot-assisted pancreatoduodenectomy [21, 22]. In this 
study, 3D-vision improved both the surgical performance 
and operative time. This is especially important considering 
the implementation of new robotic platforms and articulating 
laparoscopic instruments [9]. Clinical studies will have to 
confirm these suggestions.
What are disadvantages of 3D-vision? As confirmed in 
this study, some surgeons report discomfort when using 
3D-vision. These side effects are mostly minor and appear 
less than previously reported for 3D laparoscopy potentially 
due to the more stable camera position with robotic surgery. 
Then again, in this study all participants had at least aver-
age 3D-vision capabilities, explaining the limited amount 
of complaints. People who are unable to see stereoptically 
experience adverse effects of nausea and eye strain [23]. This 
study used the da Vinci® system. Currently, several robotic 
systems are in development and it is currently unknown 
whether these will include 3D-vision [9].
This study has some limitations. First, this was a ran-
domized trial in an experimental and not in a clinical set-
ting. A clinical study comparing the benefits of 3D-vision 
would, however, seem unlikely especially in robotic surgery 
where 3D-vision is standard of care. This study is rather 
theoretical since 3D-vision is standard for current robotic 
surgery. The reported observations could also be trans-
lated to conventional laparoscopy which does not include 
3D-vision routinely and to new robotic systems that aim to 
improve viewing conditions in minimally invasive surgery. 
A bias in familiarity with robotic surgery combined with 
3D-vision seems unlikely, as there was no significant differ-
ence between surgeons and residents, and sensitivity analysis 
revealed that the benefit of 3D-vision was similar when strat-
ifying the groups for experience. Second, participants were 
recruited on an invitational basis. This could have caused a 
Fig. 3  Time reduction to complete both anastomoses. H Hours, MM 
minutes
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selection bias toward participants with better skills or better 
stereoptic capabilities (mean seconds of arc of stereopsis of 
50 (IQR 20–130)) [14]. Third, blinding the participants for 
the intervention was clearly not possible. However, since 
the video raters were blinded for 2D and 3D-visions as they 
viewed all videos in 2D only, observer bias will not have 
played a relevant role. Unfortunately, the subjective nature 
of rating cannot be avoided, as an automated evaluation is 
not established and could also be prone to methodological 
problems.
Strengths of the current study include the randomized 
design, the use of international participants with varying 
expertise, observers blinded for 3D or 2D regarding OSATS 
outcomes, and standard description of stereoptic capa-
bilities. With the use of artificial organs, confounders of 
patient variables are eliminated, e.g., variations in pancreas 
morphology.
In conclusion, 3D-vision has a substantial, probably 
larger than expected, contribution to the value of robotic 
surgery, as compared to 2D-vision, with 25% reduction in 
operative time of completing both robotic biotissue PJ and 
HJ and 21% improved surgical performance. New robotic 
platforms and articulating laparoscopic instruments are 
advised to include 3D-vision.
Acknowledgements We would like to acknowledge all surgeons and 
residents for their dedication and involvement in completing their par-
ticipation, and theater staff for allowing robot time in all participating 
centers.
Funding This study was funded by Maag Lever Darm Stichting.
Compliance with ethical standards 
Disclosure Mr. Zwart received funding from the Amsterdam UMC 
for studies on safe implementation of robot-assisted and laparoscopic 
pancreatic surgery. He also received funding from the Dutch Digestive 
Foundation (MLDS), for studies on the before mentioned topics. Ms. 
Jones, Dr. Balduzzi, Dr. Takagi, Dr. Vanlander, Dr. van den Boezem, 
Dr. Daams, prof. Rosman, Dr. Lips, prof. Moser, prof. Hogg, prof. 
Busch, Dr. Stommel, and Prof. Besselink have no conflict of interest 
or financial ties to disclose.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
 1. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, 
Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, 
Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernan-
dez-del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert 
T, Izbicki J, Lillemoe KD, Neoptolemos JP, Olah A, Schulick R, 
Shrikhande SV, Takada T, Takaori K, Traverso W, Vollmer CR, 
Wolfgang CL, Yeo CJ, Salvia R, Buchler M (2017) The 2016 
update of the International Study Group (ISGPS) definition and 
grading of postoperative pancreatic fistula: 11 years after. Surgery 
161:584–591
 2. De Rooij T, Klompmaker S, Hilal MA, Kendrick ML, Busch 
OR, Besselink MG (2016) Laparoscopic pancreatic surgery for 
benign and malignant disease. Nat Rev Gastroenterol Hepatol 
13:227–238
 3. Sørensen SMD, Savran MM, Konge L, Bjerrum F (2016) Three-
dimensional versus two-dimensional vision in laparoscopy: a 
systematic review. Surg Endosc. https ://doi.org/10.1007/s0046 
4-015-4189-7
 4. Zwart MJW, Fuente I, Hilst J, de Rooij T, van Dieren S, van 
Rijssen LB, Schijven MP, Busch ORC, Luyer MD, Lips DJ, 
Festen S, Abu Hilal M, Besselink MG, Stibbe LA (2019) Added 
value of 3D-vision during laparoscopic biotissue pancreatico- 
and hepaticojejunostomy (LAELAPS 3D2D): an international 
randomized cross-over trial. HPB. https ://doi.org/10.1016/j.
hpb.2019.04.012
 5. Asbun HJ, Moekotte AL, Vissers FL, Kunzler F, Cipriani F, 
Alseidi A, D’Angelica MI, Balduzzi A, Bassi C, Björnsson B, 
Boggi U, Callery MP, Del Chiaro M, Coimbra FJ, Conrad C, 
Cook A, Coppola A, Dervenis C, Dokmak S, Edil BH, Edwin B, 
Giulianotti PC, Han HS, Hansen PD, Van Der Heijde N, Van Hilst 
J, Hester CA, Hogg ME, Jarufe N, Jeyarajah DR, Keck T, Kim SC, 
Khatkov IE, Kokudo N, Kooby DA, Korrel M, De Leon FJ, Lluis 
N, Lof S, Machado MA, Demartines N, Martinie JB, Merchant 
NB, Molenaar IQ, Moravek C, Mou YP, Nakamura M, Nealon 
WH, Palanivelu C, Pessaux P, Pitt HA, Polanco PM, Primrose 
JN, Rawashdeh A, Sanford DE, Senthilnathan P, Shrikhande SV, 
Stauffer JA, Takaori K, Talamonti MS, Tang CN, Vollmer CM, 
Wakabayashi G, Walsh RM, Wang SE, Zinner MJ, Wolfgang CL, 
Zureikat AH, Zwart MJ, Conlon KC, Kendrick ML, Zeh HJ, Hilal 
MA, Besselink MG (2020) The Miami international evidence-
based guidelines on minimally invasive pancreas resection. Ann 
Surg. https ://doi.org/10.1097/SLA.00000 00000 00359 0
 6. King JC, Hogg ME, Zeh HJ, Zureikat AH (2018) Robotic-assisted 
pancreaticoduodenectomy (Whipple). In: Patel AD, Oleynikov D 
(eds) The SAGES manual of robotic surgery. Springer, Cham, pp 
281–296
 7. Klompmaker S, van Hilst J, Wellner UF, Busch OR, Coratti A, 
D’Hondt M, Dokmak S, Festen S, Kerem M, Khatkov I, Lips DJ, 
Lombardo C, Luyer M, Manzoni A, Molenaar IQ, Rosso E, Saint-
Marc O, Vansteenkiste F, Wittel UA, Bonsing B, Groot Koerkamp 
B, Abu Hilal M, Fuks D, Poves I, Keck T, Boggi U, Besselink MG 
(2018) Outcomes after minimally-invasive versus open pancrea-
toduodenectomy. Ann Surg. https ://doi.org/10.1097/SLA.00000 
00000 00285 0
 8. Zhao Z, Yin Z, Hang Z, Ji G, Feng Q, Zhao Q (2017) A systemic 
review and an updated meta-analysis: minimally invasive vs open 
pancreaticoduodenectomy. Sci Rep. https ://doi.org/10.1038/s4159 
8-017-02488 -4
 9. Peters BS, Armijo PR, Krause C, Choudhury SA, Oleynikov D 
(2018) Review of emerging surgical robotic technology. Surg 
Endosc 32:1636
 10. Gosrisirikul C, Don Chang K, Raheem AA, Rha KH (2018) New 
era of robotic surgical systems. Asian J Endosc Surg 11:291–299
2935Surgical Endoscopy (2021) 35:2928–2935 
1 3
 11. Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, 
Thabane L, Lancaster GA, Altman D, Bretz F, Campbell M, Cobo 
E, Craig P, Davidson P, Groves T, Gumedze F, Hewison J, Hirst A, 
Hoddinott P, Lamb SE, Lang T, McColl E, O’Cathain A, Shana-
han DR, Sutton C, Tugwell P (2016) CONSORT 2010 statement: 
extension to randomised pilot and feasibility trials. BMJ. https ://
doi.org/10.1136/bmj.i5239 
 12. Assembly 64th WMA General (2013) WMA Declaration of 
Helsinki—s
 13. Hogg ME, Tam V, Zenati M, Novak S, Miller J, Zureikat AH, 
Zeh HJ (2017) Mastery-based virtual reality robotic simulation 
curriculum: the first step toward operative robotic proficiency. J 
Surg Educ. https ://doi.org/10.1016/j.jsurg .2016.10.015
 14. Garnham L, Sloper J (2006) Effect of age on adult stereoacuity as 
measured by different types of stereotest. Br J Ophthalmol. https 
://doi.org/10.1136/bjo.2005.07771 9
 15. Martin JA, Regehr G, Reznick R, Macrae H, Murnaghan J, Hutch-
ison C, Brown M (1997) Objective structured assessment of tech-
nical skill (OSATS) for surgical residents. Br J Surg. https ://doi.
org/10.1002/bjs.18008 40237 
 16. Birkmeyer JD, Finks JF, O’Reilly A, Oerline M, Carlin AM, Nunn 
AR, Dimick J, Banerjee M, Birkmeyer NJO (2013) Surgical skill 
and complication rates after bariatric surgery. N Engl J Med. https 
://doi.org/10.1056/NEJMs a1300 625
 17. Sullivan GM, Artino AR (2014) Analyzing and interpreting 
data from Likert-type scales. J Grad Med Educ. https ://doi.
org/10.4300/jgme-5-4-18
 18. Poves I, Burdío F, Morató O, Iglesias M, Radosevic A, Ilzarbe L, 
Visa L, Grande L (2018) Comparison of perioperative outcomes 
between laparoscopic and open approach for pancreatoduodenec-
tomy: the PADULAP randomized controlled trial. Ann Surg. https 
://doi.org/10.1097/SLA.00000 00000 00289 3
 19. Palanivelu C, Senthilnathan P, Sabnis SC, Babu NS, Srivatsan 
Gurumurthy S, Anand Vijai N, Nalankilli VP, Praveen Raj P, Par-
thasarathy R, Rajapandian S (2017) Randomized clinical trial of 
laparoscopic versus open pancreatoduodenectomy for periampul-
lary tumours. Br J Surg. https ://doi.org/10.1002/bjs.10662 
 20. de Rooij T, van Hilst J, Bosscha K, Dijkgraaf MG, Gerhards MF, 
Koerkamp BG, Hagendoorn J, de Hingh IH, Karsten TM, Lips DJ, 
Luyer MD, Molenaar IQ, van Santvoort HC, Tran TCK, Busch 
OR, Festen S, Besselink MG (2018) Minimally invasive versus 
open pancreatoduodenectomy (LEOPARD-2): study protocol for a 
randomized controlled trial. Trials. https ://doi.org/10.1186/s1306 
3-017-2423-4
 21. Hogg ME, Zenati M, Novak S, Chen Y, Jun Y, Steve J, Kowalsky 
SJ, Bartlett DL, Zureikat AH, Zeh HJ (2016) Grading of surgeon 
technical performance predicts postoperative pancreatic fistula 
for pancreaticoduodenectomy independent of patient-related vari-
ables. Ann Surg 264:482
 22. Tam V, Zenati M, Novak S, Chen Y, Zureikat AH, Zeh HJ (2017) 
Robotic pancreatoduodenectomy biotissue curriculum has validity 
and improves technical performance for surgical oncology fellows. 
J Surg Educ. https ://doi.org/10.1016/j.jsurg .2017.05.016
 23. Amin HU, Malik AS, Mumtaz W, Badruddin N, Kamel N (2015) 
Evaluation of passive polarized stereoscopic 3D display for visual 
& mental fatigues. In: Proceedings of the Annual International 
Conference of the IEEE Engineering in Medicine and Biology 
Society, EMBS
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
Affiliations
Maurice J. W. Zwart1  · Leia R. Jones1 · Alberto Balduzzi2 · Kosei Takagi3 · Aude Vanlander4 · 
Peter B. van den Boezem5 · Freek Daams6 · Camiel Rosman5 · Daan J. Lips7 · Arthur J. Moser8 · Melissa E. Hogg9 · 
Olivier R. C. Busch1 · Martijn W. J. Stommel5 · Marc G. Besselink1 · For the Dutch Pancreatic Cancer Group
 Maurice J. W. Zwart 
 m.j.zwart@amsterdamumc.nl
1 Department of Surgery, Cancer Center Amsterdam, 
Amsterdam UMC, University of Amsterdam, Amsterdam, 
The Netherlands
2 General and Pancreatic Surgery Department, Pancreas 
Institute, University and Hospital Trust of Verona, Verona, 
Italy
3 Department of Surgery, Erasmus University Medical Center, 
Rotterdam, The Netherlands
4 Department of Surgery, University Hospital Ghent, 
University of Ghent, Ghent, Belgium
5 Department of Surgery, Radboud University Nijmegen 
Medical Centre, Nijmegen, The Netherlands
6 Department of Surgery, Cancer Center Amsterdam, 
Amsterdam UMC, VU University, Amsterdam, 
The Netherlands
7 Department of Surgery, Medisch Spectrum Twente, 
Enschede, The Netherlands
8 The Pancreas and Liver Institute, Beth Israel Deaconess 
Medical Center and Harvard Medical School, Boston, MA, 
USA
9 Department of Surgery, Northshore University Health 
System, Chicago, IL, USA
